In macrophages, P. gingivalis interacts with the CD14/TLR2/TLR1 receptor complex (). Moreover, P. gingivalis uses its gingipains to attack C5 and release biologically C5a (, ). Upon C5aR binding, C5a stimulates Gαi-dependent intracellular Ca2+ signaling which synergistically enhances the otherwise weak cAMP responses induced by TLR2/TLR1 activation alone. Maximal cAMP induction is achieved by the participation of another G protein-coupled receptor, the CXCR4, which interacts directly with P. gingivalis and coassociates with both TLR2 and C5aR in lipid rafts (, ). The ensuing activation of the cAMP-dependent protein kinase A (PKA) pathway inactivates glycogen synthase kinase-3β (GSK3β) and impairs the inducible nitrogen synthase (iNOS)-dependent killing of the pathogen in macrophages in vitro and in vivo (). The interaction of P. gingivalis with TLR2/TLR1 also activates inside-out signaling, propagated by Rac1, PI3K, and cytohesin-1 (Cyt-1), which induces the high-affinity conformation of CR3 (, ). CR3 then binds and internalizes P. gingivalis; this is a relatively safe portal of entry since CR3 is not linked to vigorous microbicidal mechanisms (, ). The CR3-P. gingivalis interaction also leads to induction of ERK1/2 signaling. This in turn downregulates IL-12 p35 and p40 mRNA expression (), possibly through suppression of a critical transcription factor (the interferon regulatory factor 1 [IRF1]) that is required for IL-12 expression (). This inhibitory ERK1/2 pathway is also activated downstream of the C5aR. The suppressive effects of CR3 and C5aR on TLR2-induced cytokine production are selective for IL-12 and do not affect induction of other proinflammatory cytokines (e.g., IL-1β, IL-6, and TNF-α) in vitro or in vivo. Inhibition of bioactive IL-12 by these mechanisms results in impaired immune clearance of P. gingivalis in vivo (, ). P. gingivalis interacts with at least one more TLR, the TLR4, which, however, is proactively antagonized by an atypical lipopolysaccharide lipid A moiety ().